BAUSCH PLUS LOMB CORPBAUSCH PLUS LOMB CORPBAUSCH PLUS LOMB CORP

BAUSCH PLUS LOMB CORP

No trades
See on Supercharts
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪9.63 B‬CAD
−1.42CAD
‪−344.60 M‬CAD
‪5.50 B‬CAD
‪38.06 M‬
Beta (1Y)
0.49
Employees (FY)
‪13.3 K‬
Revenue / Employee (1Y)
‪311.73 K‬CAD
Net income / Employee (1Y)
‪−19.55 K‬CAD

About Bausch + Lomb Corporation


CEO
Brenton L. Saunders
Website
Headquarters
Vaughan
Founded
1853
FIGI
BBG014KG1FY0
Bausch + Lomb Corp. develops, manufactures, and markets eye health products. It offers over-the-counter supplements, eye care products, ophthalmic pharmaceuticals, contact lenses, lens care, ophthalmic surgical devices, and instruments. The company operates its business through three segments: Vision Care/Consumer Health Care, Ophthalmic Pharmaceuticals and Surgical. The Vision Care/Consumer Health Care segment includes both contact lens and consumer eye care businesses. The Ophthalmic Pharmaceuticals segment consists of a broad line of proprietary pharmaceutical products for post-operative treatments and treatments for a number of eye conditions, such as glaucoma, eye inflammation, ocular hypertension, dry eyes and retinal diseases. The Surgical segment consists of medical device equipment, consumables and instrumental tools and technologies for the treatment of corneal, cataracts, and vitreous and retinal eye conditions, and includes IOLs and delivery systems, phacoemulsification equipment and other surgical instruments and devices necessary for cataract surgery. Bausch + Lomb was founded by John Jacob Bausch and Henry Lomb in 1853 and is headquartered in Vaughan, Canada.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of BLCO is 26.68 CAD — it has decreased by −3.61% in the past 24 hours. Watch BAUSCH PLUS LOMB CORP stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on TSX exchange BAUSCH PLUS LOMB CORP stocks are traded under the ticker BLCO.
BLCO stock has fallen by −3.40% compared to the previous week, the month change is a −4.68% fall, over the last year BAUSCH PLUS LOMB CORP has showed a 26.45% increase.
We've gathered analysts' opinions on BAUSCH PLUS LOMB CORP future price: according to them, BLCO price has a max estimate of 36.17 CAD and a min estimate of 25.04 CAD. Watch BLCO chart and read a more detailed BAUSCH PLUS LOMB CORP stock forecast: see what analysts think of BAUSCH PLUS LOMB CORP and suggest that you do with its stocks.
BLCO reached its all-time high on Oct 15, 2024 with the price of 29.37 CAD, and its all-time low was 15.95 CAD and was reached on Jul 28, 2022. View more price dynamics on BLCO chart.
See other stocks reaching their highest and lowest prices.
BLCO stock is 3.75% volatile and has beta coefficient of 0.49. Track BAUSCH PLUS LOMB CORP stock price on the chart and check out the list of the most volatile stocks — is BAUSCH PLUS LOMB CORP there?
Today BAUSCH PLUS LOMB CORP has the market capitalization of ‪9.63 B‬, it has decreased by −0.16% over the last week.
Yes, you can track BAUSCH PLUS LOMB CORP financials in yearly and quarterly reports right on TradingView.
BAUSCH PLUS LOMB CORP is going to release the next earnings report on Feb 19, 2025. Keep track of upcoming events with our Earnings Calendar.
BLCO earnings for the last quarter are 0.23 CAD per share, whereas the estimation was 0.21 CAD resulting in a 8.10% surprise. The estimated earnings for the next quarter are 0.34 CAD per share. See more details about BAUSCH PLUS LOMB CORP earnings.
BAUSCH PLUS LOMB CORP revenue for the last quarter amounts to ‪1.62 B‬ CAD, despite the estimated figure of ‪1.59 B‬ CAD. In the next quarter, revenue is expected to reach ‪1.76 B‬ CAD.
BLCO net income for the last quarter is ‪5.41 M‬ CAD, while the quarter before that showed ‪−206.65 M‬ CAD of net income which accounts for 102.62% change. Track more BAUSCH PLUS LOMB CORP financial stats to get the full picture.
No, BLCO doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 24, 2024, the company has ‪13.30 K‬ employees. See our rating of the largest employees — is BAUSCH PLUS LOMB CORP on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. BAUSCH PLUS LOMB CORP EBITDA is ‪859.21 M‬ CAD, and current EBITDA margin is 14.13%. See more stats in BAUSCH PLUS LOMB CORP financial statements.
Like other stocks, BLCO shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade BAUSCH PLUS LOMB CORP stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So BAUSCH PLUS LOMB CORP technincal analysis shows the sell today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating BAUSCH PLUS LOMB CORP stock shows the buy signal. See more of BAUSCH PLUS LOMB CORP technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.